Salomón IS, Morales LIG, Gómez CM, López OD

Language: Spanish
References: 14
Page:
PDF size: 573.16 Kb.

ABSTRACT

Cyclosporine A (CsA), due to its immunosuppressive properties, is used in the transplantation of solid organs, bone marrow, and in some stages of certain autoimmune diseases. In Cuba, the Cyclosporine A oral solution causes gastrointestinal absorption problems.
Objectives: To achieve a pre-concentrated micro-emulsion containing highly dispersed cyclosporine A that may be equal to or higher than the one in the commercial formulation.
Methods: Study of percentages of emulsifiers and of hydrophilic lipophilic balance (HLB), at some intervals that allow obtaining self-emulsifying systems through a multilevel factorial design. The percent transmittance was used as the response variable in determining the formulation dispersion degree. The evaluation of the organoleptic characteristics of the selected formulation, the rheological study, the microbial count and the antimicrobial effectiveness estimation were all performed.
Results: The studied factors have a significant influence on the transmittance percentage, the formulation with the highest degree of dispersion was achieved when using 60% of emulsifiers and an HLB of 11.5, being transmittance values of 95.03%, which were significantly higher than those of the leading product in the form of soft capsules, equal to 84.6%. Organoleptically speaking, the product meets the characteristics of a clear brilliant fluid without suspended particles and Newtonian behavior from the rheological point of view. The bacteria and fungi count met requirements of U.S. Pharmacopoeia for oral solutions.
Conclusions: A pre-concentrate highly dispersed CsA microemulsion was achieved in a drinkable solution meeting the physical requirements and microbiological criteria established for this type of dosage form.

REFERENCES

1. Soy D, Brunet M, Roca M, Codina C, Marino E. L, Ribas J. Importancia clínica de los metabolitos de ciclosporina A (CsA) en transplantes de órganos. Determinación analítica por cromatografía líquida de alta eficacia. Farm Hos 1995; 19 (3): 155-160.

2. Faulds D, Goa K, Benfield P. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993; 45: 953-1040.

3. Formulario Nacional de Medicamentos. Cuba: Ministerio de Salud Pública Ediciones Espiral Eterna. Ciudad de La Habana. 2003. Fecha de acceso: 20: de febrero de 2011. Disponible en: http://www.dmsgbc.sld.cu/formulario/formulario.htm.

4. Bernard CS, inventor. Solid Pharmaceutical compositions comprising a cyclosporine and an anionic surfactant. United States patent US. 6,197,335 B1. 2001.

5. El-Badry M, Fetih G, Fathy M. Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG 4000. Saudi Pharmaceutical Journal 2009;17:217-25.

6. Karanth H, Shenoy VS, Murthy RR. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report. AAPS PharmSciTech 2006;7(4):87.

7. Garrige Jean- Sebastian. Les sistémes auto-emulsionnansts pour l´administration orale de principies actifs lipofhiles : Influence de la formulation sur les aspects biopharmaceutiques. Thése d` État de Docteur en Pharmacie. Unite de formation et recherche. Faculte de Pharmacie de Chatenay- Malabry. Universite de Paris XI. Diciembre 2002. 120 p.

8. N. H. Shah, W. N. Carvajal, C. I. Patel, and M. H. Infeld. Self-emulsifying drug delivery systems (SMEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994; 106: 15-23.

9. P. P. Constantinides. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 1995, 12: 1561-1572.

10. Medeiros M, Gómez A, Urizar J, Campos-Sepúlveda A, Saldaña I, Ramírez L, et al. Bioavailavility of two oral formulations of cyclosporin in uremic children before renal transplantation. Pediatr Transplantation 1998; 2: 145-9.

11. De Muth J.E. Basic statistics and Pharmaceutical statistical applications. Marcel Dekker Inc. NY. EUA, 1999.

12. Bernard CS, inventor. Emulsion preconcentrate comprising a cyplosporin, propylene carbonate, and glycerides. United States patent US 6,159,933A. 2000.

13. USP 33 NF 28 United States Pharmacopeia. Versión electrónica. 2010. Disponible en: http://www.uspnf.com/uspnf/login . Fecha de acceso: 20 de febrero de 2011.

14. Ferrán M. SPSS análisis estadístico. Mc. Graw Hill. España, 2001.